Results 1 to 10 of about 16,739,290 (349)

Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: A national observational study for the Getting It Right First Time Programme

open access: yesEClinicalMedicine, 2021
Background: A key first step in optimising COVID-19 patient outcomes during future case-surges is to learn from the experience within individual hospitals during the early stages of the pandemic.
William K. Gray   +23 more
doaj   +1 more source

Factors associated with an interruption in treatment of people living with HIV in USAID-supported states in Nigeria: a retrospective study from 2000–2020

open access: yesBMC Public Health, 2021
Background Patient interruption of antiretroviral therapy (ART) continues to limit HIV programs’ progress toward epidemic control. Multiple factors have been associated with client interruption in treatment (IIT)— including age, gender, CD4 count, and ...
Silviu Tomescu   +9 more
doaj   +1 more source

Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021

open access: yesBMJ Open, 2023
Objectives Identify factors (demographic and clinical) associated with a non-suppressed viral load (VL) of people living with HIV (PLHIV) on antiretroviral therapy (ART) in Nigeria.Design Cross-sectional study.Setting Sixteen US Agency for International ...
Charles Chasela   +9 more
doaj   +1 more source

Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors

open access: yesJournal of Neuroinflammation, 2023
Background Reinstating inflammation resolution represents an innovative concept to regain inflammation control in diseases marked by chronic inflammation. While most therapeutics target inflammatory molecules and inflammatory effector cells and mediators,
Thierry Gauthier   +12 more
doaj   +1 more source

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia

open access: yesJournal for ImmunoTherapy of Cancer, 2022
Background Acute myeloid leukemia (AML) remains a very difficult disease to cure due to the persistence of leukemic stem cells (LSCs), which are resistant to different lines of chemotherapy and are the basis of refractory/relapsed (R/R) disease in 80% of
Vincent Alcazer   +22 more
doaj   +1 more source

The Conflict between Citizens' Right to Privacy and the State's Right to Digitally Tracking People Infected or Suspected of Transmitting the Covid-19 Virus [PDF]

open access: yesFaṣlnāmah-i Pizhūhish-i Huqūq-i ̒Umūmī, 2022
The proliferation of Coronavirus around the world and the need to maintain the health of individuals in society have forced many governments to impose restrictions on citizens' rights by imposing social distances, quarantine and closure of educational ...
Sattar Azizi, Zahra Ghadbeygi
doaj   +1 more source

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect

open access: yesOncoImmunology, 2021
Background Immunosuppressive cell-based therapy is a recent strategy for controlling Graft-versus-Host Disease (GvHD). Such cells ought to maintain their suppressive function in inflammatory conditions and in the presence of immunosuppressive agents ...
Nona Janikashvili   +13 more
doaj   +1 more source

Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts

open access: yesScientific Reports, 2022
HIV treatment programs face challenges in identifying patients at risk for loss-to-follow-up and uncontrolled viremia. We applied predictive machine learning algorithms to anonymised, patient-level HIV programmatic data from two districts in South Africa,
Mhairi Maskew   +12 more
doaj   +1 more source

Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial

open access: yesBMJ Oncology, 2023
Objective Vaccinated patients with cancer in follow-up studies showed a high seropositivity rate but impaired antibody titres and T cell responses following mRNA vaccine against COVID-19.
Laura Mansi   +22 more
doaj   +1 more source

Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics

open access: yesFrontiers in Oncology, 2020
Recent studies have provided several insights into acute myeloid leukemia. Studies based on molecular biology have identified eight functional mutations involved in leukemogenesis, including driver and passenger mutations.
Xavier Roussel   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy